<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 25 Sep 2026 08:01:10 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Izotropic plans $150K private placement at $0.20 per unit</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Izotropic+plans+%24150K+private+placement+at+%240.20+per+unit/27104295.html</link>
   <description>

&lt;p&gt;Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) announced plans to complete a non-brokered private placement of 750,000 units with a strategic investor at $0.20 per unit, for gross proceeds of up to $150,000.&lt;/p&gt;

&lt;p&gt;Each unit consists of one common share and one transferable warrant. Each warrant entitles the holder to purchase one additional share at $0.30 for a period of three years from the closing of the offering.&lt;/p&gt;

&lt;p&gt;The company stated that proceeds will be used for general working capital. All securities issued will be subject to a statutory hold period of four months and one day from the date of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Izotropic+plans+%24150K+private+placement+at+%240.20+per+unit/27104295.html</guid>
   <pubDate>Fri, 25 Sep 2026 08:01:10 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	  </item>
  <item>
   <title>Izotropic plans $150K private placement at $0.20 per unit</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Izotropic+plans+%24150K+private+placement+at+%240.20+per+unit/27104295.html</link>
   <description>

&lt;p&gt;Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) announced plans to complete a non-brokered private placement of 750,000 units with a strategic investor at $0.20 per unit, for gross proceeds of up to $150,000.&lt;/p&gt;

&lt;p&gt;Each unit consists of one common share and one transferable warrant. Each warrant entitles the holder to purchase one additional share at $0.30 for a period of three years from the closing of the offering.&lt;/p&gt;

&lt;p&gt;The company stated that proceeds will be used for general working capital. All securities issued will be subject to a statutory hold period of four months and one day from the date of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Izotropic+plans+%24150K+private+placement+at+%240.20+per+unit/27104295.html</guid>
   <pubDate>Fri, 25 Sep 2026 08:01:10 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	  </item>
  <item>
   <title>Izotropic Announces Non-Brokered Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Announces+Non-Brokered+Private+Placement/27104290.html</link>
   <description>&lt;p&gt;Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - September 25, 2026) - &lt;b&gt;Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)&lt;/b&gt; (&quot;&lt;b&gt;Izotropic&lt;/b&gt;&quot;, or the &quot;&lt;b&gt;Company&lt;/b&gt;&quot;), a medical device company commercializing IzoView, a dedicated breast CT imaging system for the more accurate screening and diagnosis of breast cancers, announces the intention to complete a non-brokered private placement (the &quot;&lt;b&gt;Offering&lt;/b&gt;&quot;) with of 750,000 units of the Company with a strategic investor, (each a &quot;&lt;b&gt;Unit&lt;/b&gt;&quot;) at a price of $0.20 per each Unit for gross proceeds of up to $150K. Each Unit will consist of one common share and one transferable Warrant (each, a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Announces+Non-Brokered+Private+Placement/27104290.html</guid>
   <pubDate>Fri, 25 Sep 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	  </item>
  <item>
   <title>Izotropic Announces Non-Brokered Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Announces+Non-Brokered+Private+Placement/27104290.html</link>
   <description>&lt;p&gt;Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - September 25, 2026) - &lt;b&gt;Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)&lt;/b&gt; (&quot;&lt;b&gt;Izotropic&lt;/b&gt;&quot;, or the &quot;&lt;b&gt;Company&lt;/b&gt;&quot;), a medical device company commercializing IzoView, a dedicated breast CT imaging system for the more accurate screening and diagnosis of breast cancers, announces the intention to complete a non-brokered private placement (the &quot;&lt;b&gt;Offering&lt;/b&gt;&quot;) with of 750,000 units of the Company with a strategic investor, (each a &quot;&lt;b&gt;Unit&lt;/b&gt;&quot;) at a price of $0.20 per each Unit for gross proceeds of up to $150K. Each Unit will consist of one common share and one transferable Warrant (each, a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Announces+Non-Brokered+Private+Placement/27104290.html</guid>
   <pubDate>Fri, 25 Sep 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	  </item>
  <item>
   <title>Izotropic Announces Non-Brokered Private Placement</title>
   <link>http://www.streetinsider.com/Newsfile/Izotropic+Announces+Non-Brokered+Private+Placement/27104290.html</link>
   <description>&lt;p&gt;Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - September 25, 2026) - &lt;b&gt;Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)&lt;/b&gt; (&quot;&lt;b&gt;Izotropic&lt;/b&gt;&quot;, or the &quot;&lt;b&gt;Company&lt;/b&gt;&quot;), a medical device company commercializing IzoView, a dedicated breast CT imaging system for the more accurate screening and diagnosis of breast cancers, announces the intention to complete a non-brokered private placement (the &quot;&lt;b&gt;Offering&lt;/b&gt;&quot;) with of 750,000 units of the Company with a strategic investor, (each a &quot;&lt;b&gt;Unit&lt;/b&gt;&quot;) at a price of $0.20 per each Unit for gross proceeds of up to $150K. Each Unit will consist of one common share and one transferable Warrant (each, a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Newsfile/Izotropic+Announces+Non-Brokered+Private+Placement/27104290.html</guid>
   <pubDate>Fri, 25 Sep 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	  </item>
  <item>
   <title>Izotropic Announces Non-Brokered Private Placement</title>
   <link>http://www.streetinsider.com/Newsfile/Izotropic+Announces+Non-Brokered+Private+Placement/27104290.html</link>
   <description>&lt;p&gt;Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - September 25, 2026) - &lt;b&gt;Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)&lt;/b&gt; (&quot;&lt;b&gt;Izotropic&lt;/b&gt;&quot;, or the &quot;&lt;b&gt;Company&lt;/b&gt;&quot;), a medical device company commercializing IzoView, a dedicated breast CT imaging system for the more accurate screening and diagnosis of breast cancers, announces the intention to complete a non-brokered private placement (the &quot;&lt;b&gt;Offering&lt;/b&gt;&quot;) with of 750,000 units of the Company with a strategic investor, (each a &quot;&lt;b&gt;Unit&lt;/b&gt;&quot;) at a price of $0.20 per each Unit for gross proceeds of up to $150K. Each Unit will consist of one common share and one transferable Warrant (each, a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Newsfile/Izotropic+Announces+Non-Brokered+Private+Placement/27104290.html</guid>
   <pubDate>Fri, 25 Sep 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	  </item>
  <item>
   <title>Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  24, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNYcPwEp1LBVU3-4Uy6w8oo9uasrMRUHl_zqE5yzqryRU5PW8rcEmNSv7x1Hf81C3hJTy92tM9DvA7wGyACALjEo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=QsMbjazGMnVWCiZdWV2EhzKrsXsFU2__V8MpK1uKPnmdRzlQ3ed9elt7EIYtAUbrRUwicJ6Z3QY5Zrl-cVkrXS-JtDUTNp07KRuB1lqFkr0=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=5CeDG-wl7Q3uzbhE8aC5leRCdcAJjscO5kVrizuNXaf_VKBdpXGCFyARVL2ly6Mnk2jC7pQDbdWpzGxl1vpi48Yf8LFLykis4qsub9eUhd872CYE585rBgAQekE51b5xgOm7AgMZdnX1uVTgihlgKw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=BFzb27sIt-J2JqXxZvC-fes47UcAvwGL7JWjIrx4m4dcFRGanyp_vIVkCSE4vct8FlgplsonWz1KaejqemVLxsZmLkiFZiWLjU7klycn5wU=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNTwb7NYQfPvcQSZ_u60ptxUB241-GVAKktDmSSq5Vks1hrV1FRmbWIzFVoA2HkuI2L3e-rABqOFXns-VZdDLdG0p_Kj-Cd6fBvP1ldTSsMpC&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, &lt;em&gt;“Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market,” &lt;/em&gt;please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</guid>
   <pubDate>Fri, 24 Oct 2025 10:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  24, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNYcPwEp1LBVU3-4Uy6w8oo9uasrMRUHl_zqE5yzqryRU5PW8rcEmNSv7x1Hf81C3hJTy92tM9DvA7wGyACALjEo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=QsMbjazGMnVWCiZdWV2EhzKrsXsFU2__V8MpK1uKPnmdRzlQ3ed9elt7EIYtAUbrRUwicJ6Z3QY5Zrl-cVkrXS-JtDUTNp07KRuB1lqFkr0=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=5CeDG-wl7Q3uzbhE8aC5leRCdcAJjscO5kVrizuNXaf_VKBdpXGCFyARVL2ly6Mnk2jC7pQDbdWpzGxl1vpi48Yf8LFLykis4qsub9eUhd872CYE585rBgAQekE51b5xgOm7AgMZdnX1uVTgihlgKw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=BFzb27sIt-J2JqXxZvC-fes47UcAvwGL7JWjIrx4m4dcFRGanyp_vIVkCSE4vct8FlgplsonWz1KaejqemVLxsZmLkiFZiWLjU7klycn5wU=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNTwb7NYQfPvcQSZ_u60ptxUB241-GVAKktDmSSq5Vks1hrV1FRmbWIzFVoA2HkuI2L3e-rABqOFXns-VZdDLdG0p_Kj-Cd6fBvP1ldTSsMpC&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, &lt;em&gt;“Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market,” &lt;/em&gt;please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</guid>
   <pubDate>Fri, 24 Oct 2025 10:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  24, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNYcPwEp1LBVU3-4Uy6w8oo9uasrMRUHl_zqE5yzqryRU5PW8rcEmNSv7x1Hf81C3hJTy92tM9DvA7wGyACALjEo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=QsMbjazGMnVWCiZdWV2EhzKrsXsFU2__V8MpK1uKPnmdRzlQ3ed9elt7EIYtAUbrRUwicJ6Z3QY5Zrl-cVkrXS-JtDUTNp07KRuB1lqFkr0=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=5CeDG-wl7Q3uzbhE8aC5leRCdcAJjscO5kVrizuNXaf_VKBdpXGCFyARVL2ly6Mnk2jC7pQDbdWpzGxl1vpi48Yf8LFLykis4qsub9eUhd872CYE585rBgAQekE51b5xgOm7AgMZdnX1uVTgihlgKw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=BFzb27sIt-J2JqXxZvC-fes47UcAvwGL7JWjIrx4m4dcFRGanyp_vIVkCSE4vct8FlgplsonWz1KaejqemVLxsZmLkiFZiWLjU7klycn5wU=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNTwb7NYQfPvcQSZ_u60ptxUB241-GVAKktDmSSq5Vks1hrV1FRmbWIzFVoA2HkuI2L3e-rABqOFXns-VZdDLdG0p_Kj-Cd6fBvP1ldTSsMpC&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, &lt;em&gt;“Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market,” &lt;/em&gt;please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</guid>
   <pubDate>Fri, 24 Oct 2025 10:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  24, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNYcPwEp1LBVU3-4Uy6w8oo9uasrMRUHl_zqE5yzqryRU5PW8rcEmNSv7x1Hf81C3hJTy92tM9DvA7wGyACALjEo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=QsMbjazGMnVWCiZdWV2EhzKrsXsFU2__V8MpK1uKPnmdRzlQ3ed9elt7EIYtAUbrRUwicJ6Z3QY5Zrl-cVkrXS-JtDUTNp07KRuB1lqFkr0=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=5CeDG-wl7Q3uzbhE8aC5leRCdcAJjscO5kVrizuNXaf_VKBdpXGCFyARVL2ly6Mnk2jC7pQDbdWpzGxl1vpi48Yf8LFLykis4qsub9eUhd872CYE585rBgAQekE51b5xgOm7AgMZdnX1uVTgihlgKw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=BFzb27sIt-J2JqXxZvC-fes47UcAvwGL7JWjIrx4m4dcFRGanyp_vIVkCSE4vct8FlgplsonWz1KaejqemVLxsZmLkiFZiWLjU7klycn5wU=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNTwb7NYQfPvcQSZ_u60ptxUB241-GVAKktDmSSq5Vks1hrV1FRmbWIzFVoA2HkuI2L3e-rABqOFXns-VZdDLdG0p_Kj-Cd6fBvP1ldTSsMpC&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, &lt;em&gt;“Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market,” &lt;/em&gt;please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</guid>
   <pubDate>Fri, 24 Oct 2025 10:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  24, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNYcPwEp1LBVU3-4Uy6w8oo9uasrMRUHl_zqE5yzqryRU5PW8rcEmNSv7x1Hf81C3hJTy92tM9DvA7wGyACALjEo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=QsMbjazGMnVWCiZdWV2EhzKrsXsFU2__V8MpK1uKPnmdRzlQ3ed9elt7EIYtAUbrRUwicJ6Z3QY5Zrl-cVkrXS-JtDUTNp07KRuB1lqFkr0=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=5CeDG-wl7Q3uzbhE8aC5leRCdcAJjscO5kVrizuNXaf_VKBdpXGCFyARVL2ly6Mnk2jC7pQDbdWpzGxl1vpi48Yf8LFLykis4qsub9eUhd872CYE585rBgAQekE51b5xgOm7AgMZdnX1uVTgihlgKw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=BFzb27sIt-J2JqXxZvC-fes47UcAvwGL7JWjIrx4m4dcFRGanyp_vIVkCSE4vct8FlgplsonWz1KaejqemVLxsZmLkiFZiWLjU7klycn5wU=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNTwb7NYQfPvcQSZ_u60ptxUB241-GVAKktDmSSq5Vks1hrV1FRmbWIzFVoA2HkuI2L3e-rABqOFXns-VZdDLdG0p_Kj-Cd6fBvP1ldTSsMpC&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, &lt;em&gt;“Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market,” &lt;/em&gt;please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</guid>
   <pubDate>Fri, 24 Oct 2025 10:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  24, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNYcPwEp1LBVU3-4Uy6w8oo9uasrMRUHl_zqE5yzqryRU5PW8rcEmNSv7x1Hf81C3hJTy92tM9DvA7wGyACALjEo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=QsMbjazGMnVWCiZdWV2EhzKrsXsFU2__V8MpK1uKPnmdRzlQ3ed9elt7EIYtAUbrRUwicJ6Z3QY5Zrl-cVkrXS-JtDUTNp07KRuB1lqFkr0=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=5CeDG-wl7Q3uzbhE8aC5leRCdcAJjscO5kVrizuNXaf_VKBdpXGCFyARVL2ly6Mnk2jC7pQDbdWpzGxl1vpi48Yf8LFLykis4qsub9eUhd872CYE585rBgAQekE51b5xgOm7AgMZdnX1uVTgihlgKw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=BFzb27sIt-J2JqXxZvC-fes47UcAvwGL7JWjIrx4m4dcFRGanyp_vIVkCSE4vct8FlgplsonWz1KaejqemVLxsZmLkiFZiWLjU7klycn5wU=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNTwb7NYQfPvcQSZ_u60ptxUB241-GVAKktDmSSq5Vks1hrV1FRmbWIzFVoA2HkuI2L3e-rABqOFXns-VZdDLdG0p_Kj-Cd6fBvP1ldTSsMpC&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, &lt;em&gt;“Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market,” &lt;/em&gt;please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</guid>
   <pubDate>Fri, 24 Oct 2025 10:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  24, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNYcPwEp1LBVU3-4Uy6w8oo9uasrMRUHl_zqE5yzqryRU5PW8rcEmNSv7x1Hf81C3hJTy92tM9DvA7wGyACALjEo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=QsMbjazGMnVWCiZdWV2EhzKrsXsFU2__V8MpK1uKPnmdRzlQ3ed9elt7EIYtAUbrRUwicJ6Z3QY5Zrl-cVkrXS-JtDUTNp07KRuB1lqFkr0=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=5CeDG-wl7Q3uzbhE8aC5leRCdcAJjscO5kVrizuNXaf_VKBdpXGCFyARVL2ly6Mnk2jC7pQDbdWpzGxl1vpi48Yf8LFLykis4qsub9eUhd872CYE585rBgAQekE51b5xgOm7AgMZdnX1uVTgihlgKw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=BFzb27sIt-J2JqXxZvC-fes47UcAvwGL7JWjIrx4m4dcFRGanyp_vIVkCSE4vct8FlgplsonWz1KaejqemVLxsZmLkiFZiWLjU7klycn5wU=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNTwb7NYQfPvcQSZ_u60ptxUB241-GVAKktDmSSq5Vks1hrV1FRmbWIzFVoA2HkuI2L3e-rABqOFXns-VZdDLdG0p_Kj-Cd6fBvP1ldTSsMpC&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, &lt;em&gt;“Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market,” &lt;/em&gt;please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</guid>
   <pubDate>Fri, 24 Oct 2025 10:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  24, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNYcPwEp1LBVU3-4Uy6w8oo9uasrMRUHl_zqE5yzqryRU5PW8rcEmNSv7x1Hf81C3hJTy92tM9DvA7wGyACALjEo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=QsMbjazGMnVWCiZdWV2EhzKrsXsFU2__V8MpK1uKPnmdRzlQ3ed9elt7EIYtAUbrRUwicJ6Z3QY5Zrl-cVkrXS-JtDUTNp07KRuB1lqFkr0=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=5CeDG-wl7Q3uzbhE8aC5leRCdcAJjscO5kVrizuNXaf_VKBdpXGCFyARVL2ly6Mnk2jC7pQDbdWpzGxl1vpi48Yf8LFLykis4qsub9eUhd872CYE585rBgAQekE51b5xgOm7AgMZdnX1uVTgihlgKw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=BFzb27sIt-J2JqXxZvC-fes47UcAvwGL7JWjIrx4m4dcFRGanyp_vIVkCSE4vct8FlgplsonWz1KaejqemVLxsZmLkiFZiWLjU7klycn5wU=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=hFry9ClC3crLRgJD9gpcNTwb7NYQfPvcQSZ_u60ptxUB241-GVAKktDmSSq5Vks1hrV1FRmbWIzFVoA2HkuI2L3e-rABqOFXns-VZdDLdG0p_Kj-Cd6fBvP1ldTSsMpC&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, &lt;em&gt;“Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market,” &lt;/em&gt;please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation%E2%80%99s+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Leverages+AI+with+Next-Gen+Breast+CT+Imaging+System/25498690.html</guid>
   <pubDate>Fri, 24 Oct 2025 10:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  22, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCx2YmSlc-Um_6VkjqjqxZTjPsMCymuhNv8MieDC2xgxFPJufSk077oc1lBn9dM74oQMYWVJ1m04iXbS7Jr-qoJcQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=h9vu4BQLzkaUc80lx91j_MoLPwiBs8Y_7piWFCs74Ik7h8Z0Nw5DakMWbxA6VeisZ-YpOvQ65i1-Ab6YhgIfFlLYKwKyMmDc5MS3yWF6SAs=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=xGRN53oqiiYRQi2tfZtPMcriuvEXTfn5tirHasBZat5brU0ZAH0Y0gEUkhGqGPGPlZSdbTvqlzuvHUS7YKk_c0d-AaAIklEhxpQFSn9VyyFALO9sZDINavZ4zXXQuxx-KX4raBFN6eMnaIo4fYxuig==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=Yhy6yrPlNgN1CedBolr5Ce9lYL6JrZDu1oJ6WTPxry4HzHrkqWvOZRMKZp9MfKx_lWJJpXWmZr2kZc-5SuGusUzEJm5LcjRfSpcyuBdTeH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCxz8P3fJ5fbwf_V9Ose0wpKrNSDxQOfPiHPCBg5JNVu9xtpfl_inBlACX0gxrMJb2vW4JYKAM-y6Kr613gfqFBmIV1W2HSRHMq5H3b_tkjVXP&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</guid>
   <pubDate>Wed, 22 Oct 2025 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17568957</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22847412</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03960636</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04889877</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  22, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCx2YmSlc-Um_6VkjqjqxZTjPsMCymuhNv8MieDC2xgxFPJufSk077oc1lBn9dM74oQMYWVJ1m04iXbS7Jr-qoJcQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=h9vu4BQLzkaUc80lx91j_MoLPwiBs8Y_7piWFCs74Ik7h8Z0Nw5DakMWbxA6VeisZ-YpOvQ65i1-Ab6YhgIfFlLYKwKyMmDc5MS3yWF6SAs=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=xGRN53oqiiYRQi2tfZtPMcriuvEXTfn5tirHasBZat5brU0ZAH0Y0gEUkhGqGPGPlZSdbTvqlzuvHUS7YKk_c0d-AaAIklEhxpQFSn9VyyFALO9sZDINavZ4zXXQuxx-KX4raBFN6eMnaIo4fYxuig==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=Yhy6yrPlNgN1CedBolr5Ce9lYL6JrZDu1oJ6WTPxry4HzHrkqWvOZRMKZp9MfKx_lWJJpXWmZr2kZc-5SuGusUzEJm5LcjRfSpcyuBdTeH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCxz8P3fJ5fbwf_V9Ose0wpKrNSDxQOfPiHPCBg5JNVu9xtpfl_inBlACX0gxrMJb2vW4JYKAM-y6Kr613gfqFBmIV1W2HSRHMq5H3b_tkjVXP&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</guid>
   <pubDate>Wed, 22 Oct 2025 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17568957</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22847412</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03960636</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04889877</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  22, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCx2YmSlc-Um_6VkjqjqxZTjPsMCymuhNv8MieDC2xgxFPJufSk077oc1lBn9dM74oQMYWVJ1m04iXbS7Jr-qoJcQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=h9vu4BQLzkaUc80lx91j_MoLPwiBs8Y_7piWFCs74Ik7h8Z0Nw5DakMWbxA6VeisZ-YpOvQ65i1-Ab6YhgIfFlLYKwKyMmDc5MS3yWF6SAs=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=xGRN53oqiiYRQi2tfZtPMcriuvEXTfn5tirHasBZat5brU0ZAH0Y0gEUkhGqGPGPlZSdbTvqlzuvHUS7YKk_c0d-AaAIklEhxpQFSn9VyyFALO9sZDINavZ4zXXQuxx-KX4raBFN6eMnaIo4fYxuig==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=Yhy6yrPlNgN1CedBolr5Ce9lYL6JrZDu1oJ6WTPxry4HzHrkqWvOZRMKZp9MfKx_lWJJpXWmZr2kZc-5SuGusUzEJm5LcjRfSpcyuBdTeH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCxz8P3fJ5fbwf_V9Ose0wpKrNSDxQOfPiHPCBg5JNVu9xtpfl_inBlACX0gxrMJb2vW4JYKAM-y6Kr613gfqFBmIV1W2HSRHMq5H3b_tkjVXP&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</guid>
   <pubDate>Wed, 22 Oct 2025 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17568957</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22847412</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03960636</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04889877</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  22, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCx2YmSlc-Um_6VkjqjqxZTjPsMCymuhNv8MieDC2xgxFPJufSk077oc1lBn9dM74oQMYWVJ1m04iXbS7Jr-qoJcQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=h9vu4BQLzkaUc80lx91j_MoLPwiBs8Y_7piWFCs74Ik7h8Z0Nw5DakMWbxA6VeisZ-YpOvQ65i1-Ab6YhgIfFlLYKwKyMmDc5MS3yWF6SAs=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=xGRN53oqiiYRQi2tfZtPMcriuvEXTfn5tirHasBZat5brU0ZAH0Y0gEUkhGqGPGPlZSdbTvqlzuvHUS7YKk_c0d-AaAIklEhxpQFSn9VyyFALO9sZDINavZ4zXXQuxx-KX4raBFN6eMnaIo4fYxuig==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=Yhy6yrPlNgN1CedBolr5Ce9lYL6JrZDu1oJ6WTPxry4HzHrkqWvOZRMKZp9MfKx_lWJJpXWmZr2kZc-5SuGusUzEJm5LcjRfSpcyuBdTeH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCxz8P3fJ5fbwf_V9Ose0wpKrNSDxQOfPiHPCBg5JNVu9xtpfl_inBlACX0gxrMJb2vW4JYKAM-y6Kr613gfqFBmIV1W2HSRHMq5H3b_tkjVXP&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</guid>
   <pubDate>Wed, 22 Oct 2025 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17568957</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22847412</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03960636</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04889877</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  22, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCx2YmSlc-Um_6VkjqjqxZTjPsMCymuhNv8MieDC2xgxFPJufSk077oc1lBn9dM74oQMYWVJ1m04iXbS7Jr-qoJcQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=h9vu4BQLzkaUc80lx91j_MoLPwiBs8Y_7piWFCs74Ik7h8Z0Nw5DakMWbxA6VeisZ-YpOvQ65i1-Ab6YhgIfFlLYKwKyMmDc5MS3yWF6SAs=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=xGRN53oqiiYRQi2tfZtPMcriuvEXTfn5tirHasBZat5brU0ZAH0Y0gEUkhGqGPGPlZSdbTvqlzuvHUS7YKk_c0d-AaAIklEhxpQFSn9VyyFALO9sZDINavZ4zXXQuxx-KX4raBFN6eMnaIo4fYxuig==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=Yhy6yrPlNgN1CedBolr5Ce9lYL6JrZDu1oJ6WTPxry4HzHrkqWvOZRMKZp9MfKx_lWJJpXWmZr2kZc-5SuGusUzEJm5LcjRfSpcyuBdTeH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCxz8P3fJ5fbwf_V9Ose0wpKrNSDxQOfPiHPCBg5JNVu9xtpfl_inBlACX0gxrMJb2vW4JYKAM-y6Kr613gfqFBmIV1W2HSRHMq5H3b_tkjVXP&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</guid>
   <pubDate>Wed, 22 Oct 2025 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17568957</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22847412</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03960636</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04889877</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  22, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCx2YmSlc-Um_6VkjqjqxZTjPsMCymuhNv8MieDC2xgxFPJufSk077oc1lBn9dM74oQMYWVJ1m04iXbS7Jr-qoJcQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=h9vu4BQLzkaUc80lx91j_MoLPwiBs8Y_7piWFCs74Ik7h8Z0Nw5DakMWbxA6VeisZ-YpOvQ65i1-Ab6YhgIfFlLYKwKyMmDc5MS3yWF6SAs=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=xGRN53oqiiYRQi2tfZtPMcriuvEXTfn5tirHasBZat5brU0ZAH0Y0gEUkhGqGPGPlZSdbTvqlzuvHUS7YKk_c0d-AaAIklEhxpQFSn9VyyFALO9sZDINavZ4zXXQuxx-KX4raBFN6eMnaIo4fYxuig==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=Yhy6yrPlNgN1CedBolr5Ce9lYL6JrZDu1oJ6WTPxry4HzHrkqWvOZRMKZp9MfKx_lWJJpXWmZr2kZc-5SuGusUzEJm5LcjRfSpcyuBdTeH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCxz8P3fJ5fbwf_V9Ose0wpKrNSDxQOfPiHPCBg5JNVu9xtpfl_inBlACX0gxrMJb2vW4JYKAM-y6Kr613gfqFBmIV1W2HSRHMq5H3b_tkjVXP&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</guid>
   <pubDate>Wed, 22 Oct 2025 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17568957</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22847412</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03960636</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04889877</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  22, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCx2YmSlc-Um_6VkjqjqxZTjPsMCymuhNv8MieDC2xgxFPJufSk077oc1lBn9dM74oQMYWVJ1m04iXbS7Jr-qoJcQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=h9vu4BQLzkaUc80lx91j_MoLPwiBs8Y_7piWFCs74Ik7h8Z0Nw5DakMWbxA6VeisZ-YpOvQ65i1-Ab6YhgIfFlLYKwKyMmDc5MS3yWF6SAs=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=xGRN53oqiiYRQi2tfZtPMcriuvEXTfn5tirHasBZat5brU0ZAH0Y0gEUkhGqGPGPlZSdbTvqlzuvHUS7YKk_c0d-AaAIklEhxpQFSn9VyyFALO9sZDINavZ4zXXQuxx-KX4raBFN6eMnaIo4fYxuig==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=Yhy6yrPlNgN1CedBolr5Ce9lYL6JrZDu1oJ6WTPxry4HzHrkqWvOZRMKZp9MfKx_lWJJpXWmZr2kZc-5SuGusUzEJm5LcjRfSpcyuBdTeH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCxz8P3fJ5fbwf_V9Ose0wpKrNSDxQOfPiHPCBg5JNVu9xtpfl_inBlACX0gxrMJb2vW4JYKAM-y6Kr613gfqFBmIV1W2HSRHMq5H3b_tkjVXP&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</guid>
   <pubDate>Wed, 22 Oct 2025 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17568957</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22847412</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03960636</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04889877</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  22, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCx2YmSlc-Um_6VkjqjqxZTjPsMCymuhNv8MieDC2xgxFPJufSk077oc1lBn9dM74oQMYWVJ1m04iXbS7Jr-qoJcQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=h9vu4BQLzkaUc80lx91j_MoLPwiBs8Y_7piWFCs74Ik7h8Z0Nw5DakMWbxA6VeisZ-YpOvQ65i1-Ab6YhgIfFlLYKwKyMmDc5MS3yWF6SAs=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=xGRN53oqiiYRQi2tfZtPMcriuvEXTfn5tirHasBZat5brU0ZAH0Y0gEUkhGqGPGPlZSdbTvqlzuvHUS7YKk_c0d-AaAIklEhxpQFSn9VyyFALO9sZDINavZ4zXXQuxx-KX4raBFN6eMnaIo4fYxuig==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=Yhy6yrPlNgN1CedBolr5Ce9lYL6JrZDu1oJ6WTPxry4HzHrkqWvOZRMKZp9MfKx_lWJJpXWmZr2kZc-5SuGusUzEJm5LcjRfSpcyuBdTeH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCxz8P3fJ5fbwf_V9Ose0wpKrNSDxQOfPiHPCBg5JNVu9xtpfl_inBlACX0gxrMJb2vW4JYKAM-y6Kr613gfqFBmIV1W2HSRHMq5H3b_tkjVXP&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</guid>
   <pubDate>Wed, 22 Oct 2025 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17568957</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22847412</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03960636</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04889877</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  22, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCx2YmSlc-Um_6VkjqjqxZTjPsMCymuhNv8MieDC2xgxFPJufSk077oc1lBn9dM74oQMYWVJ1m04iXbS7Jr-qoJcQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=h9vu4BQLzkaUc80lx91j_MoLPwiBs8Y_7piWFCs74Ik7h8Z0Nw5DakMWbxA6VeisZ-YpOvQ65i1-Ab6YhgIfFlLYKwKyMmDc5MS3yWF6SAs=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=xGRN53oqiiYRQi2tfZtPMcriuvEXTfn5tirHasBZat5brU0ZAH0Y0gEUkhGqGPGPlZSdbTvqlzuvHUS7YKk_c0d-AaAIklEhxpQFSn9VyyFALO9sZDINavZ4zXXQuxx-KX4raBFN6eMnaIo4fYxuig==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=Yhy6yrPlNgN1CedBolr5Ce9lYL6JrZDu1oJ6WTPxry4HzHrkqWvOZRMKZp9MfKx_lWJJpXWmZr2kZc-5SuGusUzEJm5LcjRfSpcyuBdTeH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCxz8P3fJ5fbwf_V9Ose0wpKrNSDxQOfPiHPCBg5JNVu9xtpfl_inBlACX0gxrMJb2vW4JYKAM-y6Kr613gfqFBmIV1W2HSRHMq5H3b_tkjVXP&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</guid>
   <pubDate>Wed, 22 Oct 2025 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17568957</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22847412</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03960636</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04889877</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  22, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCx2YmSlc-Um_6VkjqjqxZTjPsMCymuhNv8MieDC2xgxFPJufSk077oc1lBn9dM74oQMYWVJ1m04iXbS7Jr-qoJcQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=h9vu4BQLzkaUc80lx91j_MoLPwiBs8Y_7piWFCs74Ik7h8Z0Nw5DakMWbxA6VeisZ-YpOvQ65i1-Ab6YhgIfFlLYKwKyMmDc5MS3yWF6SAs=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=xGRN53oqiiYRQi2tfZtPMcriuvEXTfn5tirHasBZat5brU0ZAH0Y0gEUkhGqGPGPlZSdbTvqlzuvHUS7YKk_c0d-AaAIklEhxpQFSn9VyyFALO9sZDINavZ4zXXQuxx-KX4raBFN6eMnaIo4fYxuig==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=Yhy6yrPlNgN1CedBolr5Ce9lYL6JrZDu1oJ6WTPxry4HzHrkqWvOZRMKZp9MfKx_lWJJpXWmZr2kZc-5SuGusUzEJm5LcjRfSpcyuBdTeH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCxz8P3fJ5fbwf_V9Ose0wpKrNSDxQOfPiHPCBg5JNVu9xtpfl_inBlACX0gxrMJb2vW4JYKAM-y6Kr613gfqFBmIV1W2HSRHMq5H3b_tkjVXP&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</guid>
   <pubDate>Wed, 22 Oct 2025 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17568957</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22847412</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03960636</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04889877</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
  <item>
   <title>Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</link>
   <description>
&lt;p&gt;NEW YORK, Oct.  22, 2025  (GLOBE NEWSWIRE) -- via &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCx2YmSlc-Um_6VkjqjqxZTjPsMCymuhNv8MieDC2xgxFPJufSk077oc1lBn9dM74oQMYWVJ1m04iXbS7Jr-qoJcQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorWire&lt;/a&gt; — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=h9vu4BQLzkaUc80lx91j_MoLPwiBs8Y_7piWFCs74Ik7h8Z0Nw5DakMWbxA6VeisZ-YpOvQ65i1-Ab6YhgIfFlLYKwKyMmDc5MS3yWF6SAs=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NetworkNewsWire&lt;/a&gt; (&amp;quot;NNW&amp;quot;), one of 70+ brands within the &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=xGRN53oqiiYRQi2tfZtPMcriuvEXTfn5tirHasBZat5brU0ZAH0Y0gEUkhGqGPGPlZSdbTvqlzuvHUS7YKk_c0d-AaAIklEhxpQFSn9VyyFALO9sZDINavZ4zXXQuxx-KX4raBFN6eMnaIo4fYxuig==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Dynamic Brand Portfolio&lt;/a&gt;@&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=Yhy6yrPlNgN1CedBolr5Ce9lYL6JrZDu1oJ6WTPxry4HzHrkqWvOZRMKZp9MfKx_lWJJpXWmZr2kZc-5SuGusUzEJm5LcjRfSpcyuBdTeH8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;IBN&lt;/a&gt; (&lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TSNqge1BB2ozsIfyNFoCxz8P3fJ5fbwf_V9Ose0wpKrNSDxQOfPiHPCBg5JNVu9xtpfl_inBlACX0gxrMJb2vW4JYKAM-y6Kr613gfqFBmIV1W2HSRHMq5H3b_tkjVXP&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;InvestorBrandNetwork&lt;/a&gt;), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.&lt;/p&gt;  &lt;p&gt;To view the full publication, “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” please visit: &lt;a target=&quot;_blank&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Izotropic+Corporation+%28CSE%3A+IZO%29+%28OTCQB%3A+IZOZF%29+Stands+Out+with+Proprietary+Next-Gen+Breast+CT+Imaging+System/25485978.html</guid>
   <pubDate>Wed, 22 Oct 2025 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">1R3</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17568957</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.22847412</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IZOZF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03960636</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04889877</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39023972</category>
   	  </item>
 </channel>
</rss>
